SERAPID absorbable colourless (5/0) DQL-18 needle 50 cm box of 24 sutures - Drs JOUANNY & KHAYAT - Serag-Wiessner (3O1017D5) - Delynov

What is the colorless SERAPID 5/0 suture?

The SERAPID suture from Serag-Wiessner is a Class III medical device intended for oral surgery. It is a synthetic, braided, multifilament absorbable surgical suture made from a homopolymer of glycolic acid. This thread is supplied undyed (colorless) and features a specific coating composed of calcium stearate, polycaprolactone, or sucrose fatty acid esters. Its braided structure ensures excellent handling and optimal knot security for the practitioner. Compliant with the European Pharmacopoeia, this suture material is recognized for its manufacturing quality by Serag-Wiessner GmbH & Co. KG.

What are the clinical indications for this suture thread?

This 5/0 surgical suture is specifically indicated for soft tissue adaptation in clinical situations where short-term resorption is preferred. In oral and implant surgery, it is used to suture mucous membranes after tooth extraction, implant placement, or during minor periodontal surgeries. Its design allows for precise approximation of wound edges during the initial healing phase. The choice of this 5/0 caliber is particularly suited to the delicate tissues of the oral cavity, offering a balance between tensile strength and reduced tissue trauma.

What are the technical characteristics of the DQL-18 needle?

The DQL-18 needle equipped on this SERAPID suture features precise geometric characteristics to facilitate transmucosal passage. The DQL code corresponds to a 1/4 circle curved needle with a round point. This configuration is ideal for oral soft tissues, as the round point allows for tissue penetration by spreading the fibers rather than cutting them, thus limiting the risk of tearing. Manufactured from high-quality surgical steel, the 18mm needle is swaged onto a thread with a length of 50cm, providing a comfortable working length for repetitive interventions in the dental office.

What are the contraindications for the use of the SERAPID suture?

The use of the SERAPID suture presents several major contraindications defined by the manufacturer Serag-Wiessner. It should never be used when the clinical situation requires long-term or permanent mechanical stability of the suture material. Furthermore, this device is formally contraindicated for performing ligatures, as well as for specific applications in neurosurgery or cardiovascular surgery. Finally, its use is prohibited in patients with known hypersensitivity or allergy to any of the product components, such as glycolic acid or the mentioned coating agents.

How does resorption occur and what are the precautions?

The SERAPID absorbable suture thread is absorbed by the body through a process of hydrolysis. Its technical specificity lies in its resorption speed, which is faster than that of the SERAFIT material. The practitioner must exercise caution in patients with delayed healing or in tissues with poor blood supply, as this could lead to suture extrusion or delayed resorption. It is essential to take into account the tensile strength loss characteristics when choosing this material to ensure that mechanical support is sufficient throughout the critical phase of tissue union.

Who is the manufacturer and what standards are met?

The SERAPID product is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Germany. This medical device is certified Class III and bears the CE1014 marking, guaranteeing its compliance with strict European regulatory requirements. The suture material is developed in accordance with the European Pharmacopoeia monograph relating to sterile synthetic absorbable braided sutures (fila resorbilia synthetica torta sterilia). Each box contains 24 sterile sutures under reference 3O1017D5, ensuring full traceability and compliance with safety standards for invasive surgical acts in the odontological environment.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.